1. Home
  2. FGEN vs NRT Comparison

FGEN vs NRT Comparison

Compare FGEN & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • NRT
  • Stock Information
  • Founded
  • FGEN 1993
  • NRT 1975
  • Country
  • FGEN United States
  • NRT United States
  • Employees
  • FGEN N/A
  • NRT N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • NRT Oil & Gas Production
  • Sector
  • FGEN Health Care
  • NRT Energy
  • Exchange
  • FGEN Nasdaq
  • NRT Nasdaq
  • Market Cap
  • FGEN 34.5M
  • NRT 36.1M
  • IPO Year
  • FGEN 2014
  • NRT N/A
  • Fundamental
  • Price
  • FGEN $0.50
  • NRT $4.64
  • Analyst Decision
  • FGEN
  • NRT
  • Analyst Count
  • FGEN 0
  • NRT 0
  • Target Price
  • FGEN N/A
  • NRT N/A
  • AVG Volume (30 Days)
  • FGEN 877.7K
  • NRT 51.0K
  • Earning Date
  • FGEN 02-24-2025
  • NRT 02-18-2025
  • Dividend Yield
  • FGEN N/A
  • NRT 9.55%
  • EPS Growth
  • FGEN N/A
  • NRT N/A
  • EPS
  • FGEN N/A
  • NRT 0.55
  • Revenue
  • FGEN $180,015,000.00
  • NRT $5,855,685.00
  • Revenue This Year
  • FGEN $21.91
  • NRT N/A
  • Revenue Next Year
  • FGEN N/A
  • NRT N/A
  • P/E Ratio
  • FGEN N/A
  • NRT $8.76
  • Revenue Growth
  • FGEN 16.15
  • NRT N/A
  • 52 Week Low
  • FGEN $0.18
  • NRT $3.88
  • 52 Week High
  • FGEN $2.93
  • NRT $8.62
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 49.50
  • NRT 58.54
  • Support Level
  • FGEN $0.46
  • NRT $4.75
  • Resistance Level
  • FGEN $0.51
  • NRT $5.16
  • Average True Range (ATR)
  • FGEN 0.05
  • NRT 0.25
  • MACD
  • FGEN -0.01
  • NRT 0.01
  • Stochastic Oscillator
  • FGEN 31.25
  • NRT 67.96

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks: